Young Scientist Award
Gabriela Kot – Poznan University of Medical Sciences
Gabriela Kot is a researcher affiliated with Poznan University of Medical Sciences in Poland, with scholarly activity documented across rheumatology, clinical medicine, gastrointestinal research, and related biomedical fields. Her ORCID record identifies seven works and provides evidence of continued engagement with peer-reviewed research. [1] Her publication portfolio includes studies addressing rheumatoid arthritis, monoclonal antibody therapy, thrombotic microangiopathy, digestive-system biology, and clinical outcomes. [2]
Abstract
Gabriela Kot’s documented research activity represents a multidisciplinary biomedical profile with particular relevance to rheumatology and clinical research. Her record includes seven works, while the supplied bibliometric information reports nine citations and an h-index of 2. The publication record includes observational research, therapeutic comparisons, case-based clinical investigation, and studies of disease mechanisms. Her work on rheumatoid arthritis and monoclonal antibodies is especially aligned with pharmaceutical and therapeutic research, providing a relevant basis for consideration within a Young Scientist Award framework. [3]
Keywords
Gabriela Kot; Young Scientist Award; Rheumatology; Rheumatoid Arthritis; Monoclonal Antibodies; Clinical Research; Therapeutics; Thrombotic Microangiopathy; Biomedical Research; Pharmaceutical Research.
Introduction
The research record of Gabriela Kot demonstrates participation in contemporary biomedical investigations spanning rheumatology, clinical medicine, gastroenterology, nephrology, and therapeutic science. The available ORCID information confirms employment at the Poznan University of Medical Sciences and lists seven research works. [1] This breadth indicates an interdisciplinary approach in which clinical observations and disease-focused studies contribute to the broader evidence base.
Research Profile
The supplied profile identifies Rheumatology as the principal subject area and reports seven documents, nine citations, and an h-index of 2. Her publications include research concerning rheumatoid arthritis, particularly antinuclear antibodies and monoclonal antibody treatment, alongside investigations in other clinical domains. The profile therefore reflects developing research experience supported by a varied publication portfolio.[4]
Research Contributions
Among the documented contributions is a cross-sectional observational study examining antinuclear antibodies in rheumatoid arthritis, providing clinical evidence relevant to disease characterization. [4] Another publication compares the efficacy and safety of monoclonal antibodies in rheumatoid arthritis, directly connecting her research activity with therapeutic evaluation. [5] Additional works address rare clinical complications, gastrointestinal biology, surveillance, and quality-of-life outcomes.
Publications
The publication record contains seven works listed in the supplied ORCID document, including journal articles published in 2024, 2025, and 2026. [1] The works include studies in Antibodies, Cancers, Medicina, Biochemical and Biophysical Research Communications, and the American Journal of Case Reports. Several records provide DOI identifiers, enabling direct verification through publisher or DOI services.[4]
Research Impact
The supplied bibliometric profile records nine citations and an h-index of 2, indicating measurable scholarly uptake of the documented publications. [3] The research themes also have practical relevance because they encompass therapeutic safety, disease assessment, clinical surveillance, and patient outcomes. Continued publication in peer-reviewed journals and further development of focused rheumatology research may strengthen the long-term visibility and impact of this emerging research profile.[4]
Award Suitability
Gabriela Kot’s documented publication activity and identified subject area provide a reasonable scholarly basis for consideration for the Young Scientist Award. Her work directly includes rheumatoid arthritis and monoclonal antibody research, subjects relevant to pharmaceutical and therapeutic sciences. [4] The multidisciplinary nature of her other publications further demonstrates engagement with clinically relevant biomedical questions, although award decisions should remain subject to the formal evaluation criteria of the International Top Pharmaceutical Awards. [1]
Conclusion
Gabriela Kot has an emerging research profile centered on rheumatology and supported by publications across several biomedical disciplines. The available record documents seven works, nine citations, and an h-index of 2, together with research addressing rheumatoid arthritis, therapeutic antibodies, clinical complications, and related medical questions.These activities establish a relevant foundation for continued scientific development and consideration within an early-career research recognition framework. [1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Gabriela Kot, Author ID 59492769200. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=59492769200
- Kot, G., et al. (2026). Diagnostic Challenges in Atypical Hemolytic Uremic Syndrome: A Case of Artificial Mitral Valve Dysfunction as a Possible Trigger for Severe Thrombotic Microangiopathy. American Journal of Case Reports. DOI: 10.12659/AJCR.948516.
https://doi.org/10.12659/AJCR.948516
- Cholerzyńska, H., Kot, G., Świątek, Ł., & Grygiel-Górniak, B. (2026). Beyond the Surface: Antinuclear Antibodies in Rheumatoid Arthritis—Experiences from a Single-Center, Cross-Sectional Observational Study. Antibodies, 15(4), 58. DOI: 10.3390/antib15040058.
https://doi.org/10.3390/antib15040058
- Kot, G., Świątek, Ł., Sikorska, D., & Samborski, W. (2025). Comparative efficacy and safety of monoclonal antibodies in rheumatoid arthritis. Wydawnictwo Akademia Medycyny. DOI: 10.53139/FW.20251806.
https://doi.org/10.53139/FW.20251806
- ORCID. (2026). Gabriela Kot, ORCID record and works. ORCID.
https://orcid.org/0009-0004-3205-6225